EUVIMEDEUVIMED entdecken
Fallbericht

Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile

Zi-Ling Mai, Bing Chang, Yi-Ling Li, Hong Wei, Bo-Tong Ma

MedScience · 2026-08 · 20 (4) · 739-743

DOI: 10.1007/s11684-026-1232-0 ↗

Kurz gefasst

Fallbericht in der Zeitschrift MedScience, online erschienen am 18.09.2026. Verfasst von Zi-Ling Mai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Cirrhosis, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated fatty liver disease (MAFLD) usually progresses slowly, but some patients experience exceptionally rapid deterioration. We report a 38-year-old woman who progressed from biopsy-confirmed steatosis to decompensated cirrhosis within 11 months and developed recurrent graft steatosis 8 months after liver transplantation. Genetic testing revealed heterozygous variants in PNPLA3, TM6SF2, MBOAT7, and GCKR, indicating a polygenic predisposition to lipid accumulation, inflammation, and fibrogenesis. Histology and imaging analyses showed progressive steatosis with bridging fibrosis before transplantation and severe recurrence within the graft after transplantation, highlighting that transplantation does not eliminate the underlying metabolic-genetic vulnerability. This case suggests that a polygenic background may contribute to ultra-rapid disease trajectories and supports integrating genetic profiling into diagnostic and prognostic evaluation for MAFLD. Awareness of such risk patterns may guide early surveillance and long-term metabolic management even after transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiver CirrhosisFatty LiverNon-alcoholic Fatty Liver DiseaseHumansFemaleAdultDisease ProgressionMembrane ProteinsLipaseAcyltransferasesMultifactorial InheritanceGenetic Predisposition to DiseasePhospholipases A2, Calcium-IndependentGenetic Risk Score

Stichwörter der Autor:innen

GCKRMBOAT7PNPLA3TM6SF2cirrhosisliver transplantationmetabolic dysfunction-associated fatty liver disease

Substanzen

Membrane ProteinsLipaseAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
  • Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang, 110001, China. cb000216@163.com.

Zitieren

APA

Mai, Z. L., Chang, B., Li, Y. L., Wei, H., & Ma, B. T. (2026). Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile. MedScience, 20(4), 739-743. https://doi.org/10.1007/s11684-026-1232-0

Vancouver

Mai ZL, Chang B, Li YL, Wei H, Ma BT. Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile. MedScience. 2026;20(4):739-743. doi:10.1007/s11684-026-1232-0

BibTeX
@article{Mai2026,
  author = {Mai, Zi-Ling and Chang, Bing and Li, Yi-Ling and Wei, Hong and Ma, Bo-Tong},
  title = {Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile},
  journal = {MedScience},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {739--743},
  doi = {10.1007/s11684-026-1232-0}
}
Kostenlos starten →